Abecelisil Tablet is a medication used to treat breast cancer.
Abciximil Tablets may be used in combination with endocrine therapy or aromatase inhibitors for the adjuvant treatment of adult patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, lymph node-positive, early-stage breast cancer at high risk of recurrence and with Ki-67 ≥ 20%. It may also be used for the treatment of patients with locally advanced or metastatic breast cancer who are hormone receptor positive and human epidermal growth factor receptor 2 negative.
Common adverse reactions caused by abexceli tablets include diarrhea, leukopenia, neutropenia, anemia, nausea and vomiting, decreased appetite, and hair loss. Abecyclis tablets must be used under the supervision of a physician experienced in antitumor therapy and must be properly monitored during treatment with the drug. It is contraindicated for those who are allergic to any of the ingredients contained in the drug.
Breast cancer patients using abecyclidine tablets, must do strictly follow the doctor’s instructions to use the drug, individuals must not be abused, so as not to delay or aggravate the condition.